撤回：血清CA125、CA199和HE4在早期卵巢癌女性中的临床诊断价值分析：系统评价与Meta分析
Retracted: A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis.
作者信息
Methods In Medicine Computational And Mathematical
出版信息
Comput Math Methods Med. 2023 Jul 19;2023:9847176. doi: 10.1155/2023/9847176. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/9339325.].
摘要
[本文撤回文章DOI: 10.1155/2022/9339325。]
相似文献
1
Retracted: A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis.撤回：血清CA125、CA199和HE4在早期卵巢癌女性中的临床诊断价值分析：系统评价与Meta分析
Comput Math Methods Med. 2023 Jul 19;2023:9847176. doi: 10.1155/2023/9847176. eCollection 2023.
2
A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis.血清 CA125、CA199 和 HE4 对早期卵巢癌患者的临床诊断价值分析：系统评价和荟萃分析。
Comput Math Methods Med. 2022 May 25;2022:9339325. doi: 10.1155/2022/9339325. eCollection 2022.
3
The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta-analysis.人附睾蛋白 4（HE4）在鉴别良恶性盆腔肿块中的诊断准确性：系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2021 Oct;100(10):1788-1799. doi: 10.1111/aogs.14224. Epub 2021 Jul 19.
4
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.上皮性卵巢癌患者卵巢恶性肿瘤风险的诊断措施比较：一项荟萃分析。
Sci Rep. 2021 Aug 27;11(1):17308. doi: 10.1038/s41598-021-96552-9.
5
The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.18F-FDG PET/CT 显像联合 CA125 和 HE4 检测在卵巢癌复发转移诊断中的价值。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7276-7283. doi: 10.26355/eurrev_202007_21882.
6
Comparison of diagnostic values between CA125 combined with CA199 and ultrasound combined with CT in ovarian cancer.CA125联合CA199与超声联合CT在卵巢癌诊断价值上的比较。
Oncol Lett. 2019 Jun;17(6):5523-5528. doi: 10.3892/ol.2019.10264. Epub 2019 Apr 18.
7
Clinical Value of Serum HE4, CA125, CA72-4, and ROMA Index for Diagnosis of Ovarian Cancer and Prediction of Postoperative Recurrence.血清HE4、CA125、CA72-4及ROMA指数在卵巢癌诊断及术后复发预测中的临床价值
Clin Lab. 2019 Apr 1;65(4). doi: 10.7754/Clin.Lab.2018.181030.
8
Early diagonosis of ovarian cancer: serum HE4, CA125 and ROMA model.卵巢癌的早期诊断：血清人附睾蛋白4、癌抗原125及ROMA模型
Am J Transl Res. 2021 Dec 15;13(12):14141-14148. eCollection 2021.
9
Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women.尿CA125和HE4用于检测有症状女性的卵巢癌
Cancers (Basel). 2023 Feb 16;15(4):1256. doi: 10.3390/cancers15041256.
10
Retracted: Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125.撤回：益气养阴汤联合多西他赛治疗晚期卵巢癌的临床疗效及对血清标志物VEGF、HE4和CA125水平的影响
J Healthc Eng. 2023 Jul 12;2023:9834612. doi: 10.1155/2023/9834612. eCollection 2023.
引用本文的文献
1
New use of preoperative fibrinogen in ovarian cancer management.术前纤维蛋白原在卵巢癌治疗中的新用途。
Transl Cancer Res. 2023 Nov 30;12(11):3105-3112. doi: 10.21037/tcr-23-908. Epub 2023 Oct 26.
本文引用的文献
1
A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis.血清 CA125、CA199 和 HE4 对早期卵巢癌患者的临床诊断价值分析：系统评价和荟萃分析。
Comput Math Methods Med. 2022 May 25;2022:9339325. doi: 10.1155/2022/9339325. eCollection 2022.
Zotero 插件